St. Jude Medical Plans $30 Million Device Plant In Malaysia
This article was originally published in PharmAsia News
Executive Summary
U.S. device maker St. Jude Medical plans a $30 million investment in Malaysia, building a large facility to serve as the basis for a manufacturing expansion. The company plans to begin on the office and plant combination this year with plans to begin operations in 2011. According to a government minister, St. Jude plans to kick off the facility by producing its cardiac rhythm management devices. The facility expects to employ about 300 Malaysians initially, but has the room to create as many as 1,000 jobs in the future. (Click here for more
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.